Strategy toward Kinase-Selective Drug Discovery
Journal of Chemical Theory and Computation · 14.03.2023 · 19 (5) · 1615-1628
DOI: 10.1021/acs.jctc.2c01171 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Theory and Computation, online erschienen am 23.02.2023. Verfasst von Mingzhen Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Computational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States. Hauptthemen laut MEDLINE: Artificial Intelligence, Protein Kinase Inhibitors. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Computational Structural Biology Section, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States.
- Cancer Innovation Laboratory, National Cancer Institute, Frederick, Maryland 21702, United States.
- Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
ORCID-Profile: Hyunbum Jang, Ruth Nussinov
Förderung
- National Cancer Institute
Zitieren
APA
Zhang, M., Liu, Y., Jang, H., & Nussinov, R. (2023). Strategy toward Kinase-Selective Drug Discovery. Journal of Chemical Theory and Computation, 19(5), 1615-1628. https://doi.org/10.1021/acs.jctc.2c01171
Vancouver
Zhang M, Liu Y, Jang H, Nussinov R. Strategy toward Kinase-Selective Drug Discovery. Journal of Chemical Theory and Computation. 2023;19(5):1615-1628. doi:10.1021/acs.jctc.2c01171
BibTeX
@article{Zhang2023,
author = {Zhang, Mingzhen and Liu, Yonglan and Jang, Hyunbum and Nussinov, Ruth},
title = {Strategy toward Kinase-Selective Drug Discovery},
journal = {Journal of Chemical Theory and Computation},
year = {2023},
volume = {19},
number = {5},
pages = {1615--1628},
doi = {10.1021/acs.jctc.2c01171}
}
EUVIMED